Tributary Capital Management, LLC Enovis Corp Transaction History

Tributary Capital Management, LLC

$994 Million
Q4 2025

A detailed history of Tributary Capital Management, LLC transactions in Enovis Corp stock. As of the latest transaction made, Tributary Capital Management, LLC holds 527,707 shares of ENOV stock, worth $15.8 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares

527,707

Previous 577,241 8.58%

Holding current value

$15.8 Million

Previous $17.5 Million 9.64%

% of portfolio

1.59%

Previous 1.59%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 27, 2026	SELL	$28.06 - $32.87 $1.39 Million - $1.63 Million	-49,534 Reduced 8.58%	527,707 $15.8 Million
Q3 2025 Jan 27, 2026	SELL	$25.74 - $35.94 $14.9 Million - $20.7 Million	-577,241 Reduced 50.0%	577,241 $17.5 Million
Q3 2025 Oct 23, 2025	BUY	$25.74 - $35.94 $14.2 Million - $19.8 Million	551,613 Added 91.5%	1,154,482 $35 Million
Q2 2025 Jul 30, 2025	SELL	$29.65 - $37.35 $256,650 - $323,301	-8,656 Reduced 1.42%	602,869 $18.9 Million
Q1 2025 May 02, 2025	BUY	$35.51 - $47.99 $1.61 Million - $2.18 Million	45,436 Added 8.03%	611,525 $23.4 Million

Q4 2024 Jan 21, 2025	BUY	$38.5 - $49.33 $5.52 Million - $7.07 Million	143,258 Added 33.88%	566,089 $24.9 Million
Q3 2024 Oct 24, 2024	BUY	$40.57 - $48.1 $553,415 - $656,132	13,641 Added 3.33%	422,831 $18.2 Million
Q2 2024 Jul 24, 2024	BUY	$44.56 - $62.43 $3.16 Million - $4.42 Million	70,819 Added 20.93%	409,190 $18.5 Million
Q1 2024 Apr 18, 2024	BUY	$55.44 - $63.8 $2.54 Million - $2.92 Million	45,745 Added 15.63%	338,371 $21.1 Million
Q4 2023 Jan 16, 2024	BUY	$43.67 - $57.07 $1.65 Million - $2.16 Million	37,858 Added 14.86%	292,626 $16.4 Million
Q3 2023 Oct 11, 2023	BUY	$51.65 - $65.54 $13.2 Million - $16.7 Million	254,768 New	254,768 $13.4 Million

About Enovis CORP

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $1.62B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

More about ENOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tributary Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tributary Capital Management, LLC with notifications on news.

Account

Tributary Capital Management, LLC Enovis Corp Transaction History